IGI Reports Third Quarter and First Nine Months of 2024 Unaudited Financial Results
Highlights for the third quarter and first nine months of 2024 include:
(in millions of |
||||
|
Quarter Ended |
Nine Months Ended |
||
|
2024 |
2023 |
2024 |
2023 |
Gross written premiums |
|
|
|
|
Net premiums earned |
|
|
|
|
Underwriting income (1) |
|
|
|
|
Net investment income |
|
|
|
|
Net income for the period |
|
|
|
|
Combined ratio (1) |
86.0% |
73.2% |
80.5% |
74.9% |
Earnings per share (diluted) (2) |
|
|
|
|
Return on average equity (annualized) (3) |
22.3% |
9.3% |
23.5% |
25.8% |
Core operating income (3) |
|
|
|
|
Core operating earnings per share (diluted) (3) |
|
|
|
|
Core operating return on average equity (annualized) (3) |
19.8% |
31.0% |
23.2% |
31.4% |
(1) |
See “Supplementary Financial Information” below. |
|
(2) |
See “Note to the Consolidated Financial Statements (Unaudited)” below. |
|
(3) |
See the section titled “Non-GAAP Financial Measures” below. |
“As we look ahead to 2025, we are in our strongest position ever, with a solid and consistently growing capital base. At
“As always, consistent and sustainable value creation is at the core of everything we do at
Results for the Periods ended
Net income for the quarter ended
Return on average equity (annualized) was 22.3% for the third quarter of 2024, compared to 9.3% for the third quarter of 2023.
Core operating income, a non-GAAP measure, was
Gross written premiums were
The loss ratio was 51.5% for the quarter ended
The net policy acquisition expense ratio was 15.6% in the third quarter of 2024 compared to 17.1% in the same quarter of 2023.
The general & administrative expense ratio was 18.9% for the quarter ended
The combined ratio for the quarter ended
Net income for the nine months ended
Return on average equity (annualized) was 23.5% for the first nine months of 2024, compared to 25.8% for the first nine months of 2023.
Core operating income, a non-GAAP measure, was
Underwriting income remained relatively flat at
Gross written premiums were
The loss ratio for the nine months ended
The net policy acquisition expense ratio was 16.4% in the first nine months of 2024, compared to 17.5% in the same period of 2023.
The general & administrative expense ratio was 18.8% for the first nine months of 2024 compared to 16.9% for the first nine months of 2023, largely driven by higher human resources costs in line with the Company’s growth.
The combined ratio for the nine months ended
Segment Results
The Specialty Short-tail Segment, which represented 58% of the Company’s gross written premiums for the nine months ended
Gross written premiums for the nine months ended
The Specialty Long-tail Segment, which represented 27% of the Company’s gross written premiums for the nine months ended
Gross written premiums for the nine months ended
The Reinsurance Segment, which represented 15% of the Company’s gross written premiums for the nine months ended
Gross written premiums for the nine months ended
Investment Results
Investment income increased by 26.0% to
Investment income increased 31.9% to
Net Foreign Exchange Gain (Loss)
The net foreign exchange gain in the third quarter of 2024 was
The net foreign exchange gain in the first nine months of 2024 was
Total Shareholders’ Equity
Total shareholders’ equity at
(in millions of |
Quarter Ended
|
Nine Months Ended |
Total Shareholders’ equity at beginning of period |
|
|
Net income for the period |
|
|
Unrealized gains during the period on available-for-sale investments |
|
|
Change in foreign currency translation reserve |
- |
|
Purchase of treasury shares (a) |
( |
( |
Share-based compensation expense during the period |
|
|
Vesting of earnout shares |
|
|
Cash dividends declared during the period |
( |
( |
Total shareholders’ equity at |
|
|
Book value per share was
(a) |
In the third quarter of 2024, the Company repurchased approximately 341,592 common shares at an average price per share of |
|
||||||||
Consolidated Statements of Income (Unaudited) |
||||||||
|
||||||||
|
Quarter Ended |
Nine Months Ended |
||||||
(in millions of |
2024 |
2023 |
2024 |
2023 |
||||
|
|
|
|
|
||||
Gross written premiums |
|
|
|
|
||||
Ceded written premiums |
( |
( |
( |
( |
||||
Net written premiums |
|
|
|
|
||||
Net change in unearned premiums |
|
|
( |
( |
||||
Net premiums earned |
|
|
|
|
||||
Investment income |
|
|
|
|
||||
Net realized gain on investments |
|
|
|
|
||||
Net unrealized (loss) gain on investments |
( |
( |
|
|
||||
Change in allowance for expected credit losses on investments |
|
( |
( |
|
||||
Net investment income |
|
|
|
|
||||
Other revenues |
|
|
|
|
||||
Total revenues |
|
|
|
|
||||
Expenses |
|
|
|
|
||||
Net loss and loss adjustment expenses |
( |
( |
( |
( |
||||
Net policy acquisition expenses |
( |
( |
( |
( |
||||
General & administrative expenses |
( |
( |
( |
( |
||||
Change in allowance for expected credit losses on receivables |
( |
|
( |
( |
||||
Change in fair value of derivative financial liabilities |
( |
( |
( |
( |
||||
Other expenses |
( |
( |
( |
( |
||||
Net Foreign exchange gain (loss) |
|
( |
|
( |
||||
Total expenses |
( |
( |
( |
( |
||||
Net income before tax |
|
|
|
|
||||
Income tax expense |
( |
( |
( |
( |
||||
Net income for the period |
|
|
|
|
||||
Diluted earnings per share attributable to equity holders (1) |
|
|
|
|
(1) |
See “Note to the Consolidated Financial Statements (Unaudited)” |
|
||||
Consolidated Balance Sheets (Unaudited) |
||||
|
||||
(in millions of |
As at |
As at |
||
ASSETS |
|
|
||
Investments |
|
|
||
Fixed maturity securities available-for-sale, at fair value |
|
|
||
Fixed maturity securities held to maturity |
|
|
||
Equity securities, at fair value |
|
|
||
Other investments |
|
|
||
Short-term investments |
|
|
||
Term deposits |
|
|
||
Equity-method investments measured at fair value |
|
|
||
Total investments |
|
|
||
Cash and cash equivalents |
|
|
||
Accrued investment income |
|
|
||
Premiums receivable |
|
|
||
Reinsurance recoverables |
|
|
||
Ceded unearned premiums |
|
|
||
Deferred policy acquisition costs, net of ceding commissions |
|
|
||
Deferred tax assets, net |
|
|
||
Other assets |
|
|
||
TOTAL ASSETS |
|
|
||
|
|
|
||
LIABILITIES |
|
|
||
Reserve for unpaid loss and loss adjustment expenses |
|
|
||
Unearned premiums |
|
|
||
Other liabilities |
|
|
||
Insurance and reinsurance payables |
|
|
||
Derivative financial liabilities |
- |
|
||
TOTAL LIABILITIES |
|
|
||
|
|
|
||
SHAREHOLDERS’ EQUITY |
|
|
||
Common shares at par value |
|
|
||
Additional paid-in capital |
|
|
||
|
( |
- |
||
Accumulated other comprehensive income, net of taxes |
|
|
||
Foreign currency translation reserve |
( |
( |
||
Fair value reserve |
|
( |
||
Retained earnings |
|
|
||
TOTAL SHAREHOLDERS’ EQUITY |
|
|
||
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY |
|
|
|
||||||||
Supplementary Financial Information – Combined Ratio (Unaudited) |
||||||||
|
||||||||
|
Quarter Ended |
|
Nine Months Ended |
|||||
|
2024 |
|
2023 |
|
2024 |
|
2023 |
|
|
|
|
|
|
||||
Loss ratio (a) |
51.5% |
37.3% |
45.3% |
40.5% |
||||
Net policy acquisition expense ratio (b) |
15.6% |
17.1% |
16.4% |
17.5% |
||||
General and administrative expense ratio (c) |
18.9% |
18.8% |
18.8% |
16.9% |
||||
Expense ratio (d) |
34.5% |
35.9% |
35.2% |
34.4% |
||||
Combined ratio (e) |
86.0% |
73.2% |
80.5% |
74.9% |
(a) |
Represents net loss and loss adjustment expenses as a percentage of net premiums earned. |
|
(b) |
Represents net policy acquisition expenses as a percentage of net premiums earned. |
|
(c) |
Represents general and administrative expenses as a percentage of net premiums earned. |
|
(d) |
Represents the sum of the net policy acquisition expenses ratio and the general and administrative expense ratio. |
|
(e) |
Represents the sum of the loss ratio and the expense ratio. |
|
||||
Supplementary Financial Information – Book Value per Share (Unaudited) |
||||
|
||||
(in millions of |
As at |
As at |
||
Investments |
|
|
||
Cash and cash equivalents |
|
|
||
Total investments and cash and cash equivalents |
|
|
||
|
|
|
||
Common shares outstanding (in millions)* |
45.3 |
46.1 |
||
Minus: Unvested shares (in millions)** |
1.0 |
2.5 |
||
Number of vested common outstanding shares (in millions) (a) |
44.3 |
43.6 |
||
|
|
|
||
Total shareholders’ equity (b) |
|
|
||
Book value per share (b)/(a) |
|
|
* Common shares issued and outstanding as at
|
No. of shares as at |
|
|
Vested common shares as of |
43,584,549 |
|
3,800 |
Vested restricted share awards |
397,293 |
Vested earnout shares |
1,612,500 |
Cancelled treasury shares |
(1,083,203) |
|
(176,864) |
Total vested common shares as of |
44,338,075 |
|
|
Unvested earnout shares as of |
- |
Unvested restricted share awards as of |
1,002,665 |
Total unvested shares as of |
1,002,665 |
Total common shares outstanding as of |
45,340,740 |
** |
3,012,500 Earnout Shares were originally subject to vesting at stock prices ranging from |
Supplementary Financial Information - Segment Results (Unaudited)
Segment information for IGI’s consolidated operations is as follows:
|
|||||||
For the quarter ended |
|||||||
(in millions of |
Specialty |
|
Specialty |
|
Reinsurance |
|
Total |
Underwriting revenues |
|
|
|
|
|
|
|
Gross written premiums |
|
|
|
|
|
|
|
Ceded written premiums |
( |
|
( |
|
- |
|
( |
Net written premiums |
|
|
|
|
|
|
|
Net change in unearned premiums |
|
|
|
|
|
|
|
Net premiums earned |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss and loss adjustment expenses |
( |
|
( |
|
( |
|
( |
Net policy acquisition expenses |
( |
|
( |
|
( |
|
( |
Underwriting income |
( |
|
|
|
|
|
|
For the quarter ended |
|||||||
(in millions of |
Specialty |
|
Specialty |
|
Reinsurance |
|
Total |
Underwriting revenues |
|
|
|
|
|
|
|
Gross written premiums |
|
|
|
|
|
|
|
Ceded written premiums |
( |
|
( |
|
- |
|
( |
Net written premiums |
|
|
|
|
|
|
|
Net change in unearned premiums |
( |
|
|
|
( |
|
|
Net premiums earned |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss and loss adjustment expenses |
( |
|
( |
|
( |
|
( |
Net policy acquisition expenses |
( |
|
( |
|
( |
|
( |
Underwriting income |
|
|
|
|
|
|
|
Supplementary Financial Information - Segment Results (Unaudited) |
|||||||
|
|||||||
For the nine months ended |
|||||||
(in millions of |
Specialty |
|
Specialty |
|
Reinsurance |
|
Total |
Underwriting revenues |
|
|
|
|
|
|
|
Gross written premiums |
|
|
|
|
|
|
|
Ceded written premiums |
( |
|
( |
|
( |
|
( |
Net written premiums |
|
|
|
|
|
|
|
Net change in unearned premiums |
|
|
|
|
( |
|
( |
Net premiums earned |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss and loss adjustment expenses |
( |
|
( |
|
( |
|
( |
Net policy acquisition expenses |
( |
|
( |
|
( |
|
( |
Underwriting income |
|
|
|
|
|
|
|
For the nine months ended |
|||||||
(in millions of |
Specialty |
|
Specialty |
|
Reinsurance |
|
Total |
Underwriting revenues |
|
|
|
|
|
|
|
Gross written premiums |
|
|
|
|
|
|
|
Ceded written premiums |
( |
|
( |
|
- |
|
( |
Net written premiums |
|
|
|
|
|
|
|
Net change in unearned premiums |
|
|
( |
|
( |
|
( |
Net premiums earned |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss and loss adjustment expenses |
( |
|
( |
|
( |
|
( |
Net policy acquisition expenses |
( |
|
( |
|
( |
|
( |
Underwriting income |
|
|
|
|
|
|
|
|
||||||||
Supplementary Financial Information – Investment Yield (Unaudited) |
||||||||
|
||||||||
The following table shows the investment yield calculation: |
||||||||
|
||||||||
|
Quarter Ended |
Nine Months Ended |
||||||
(in millions of |
2024 |
2023 |
2024 |
2023 |
||||
Investment income |
|
|
|
|
||||
Average total investments and cash and cash equivalents(i) |
|
|
1,190.9 |
|
||||
Investment Yield (annualized) |
4.2% |
3.9% |
4.3% |
3.8% |
(i) |
This represents the average of the month end fair value balances of total investments and cash and cash equivalents in each reporting period. |
|
||
Note to the Consolidated Financial Statements (Unaudited) |
||
(1) |
Represents net income for the period available to common shareholders divided by the weighted average number of vested common shares – diluted calculated as follows: |
|
Quarter Ended |
|
Nine Months Ended |
|||||
(in millions of |
2024 |
|
2023 |
|
2024 |
|
2023 |
|
Net income for the period |
|
|
|
|
||||
Minus: Net income attributable to the earnout shares |
|
|
|
|
||||
Minus: Dividends attributable to restricted share awards |
- |
- |
|
- |
||||
Net income available to common shareholders (a) |
|
|
|
|
||||
Weighted average number of shares – diluted (in millions of shares) (b)* |
45.8 |
43.0 |
44.6 |
43.7 |
||||
Diluted earnings per share attributable to equity holders (a/b) |
|
|
|
|
* |
The weighted average number of common shares refers to the number of common shares calculated after adjusting for the changes in issued and outstanding common shares over a reporting period. |
Non-GAAP Financial Measures
In presenting IGI’s financial results, management has included and discussed certain non-GAAP financial measures. We believe that these non-GAAP measures, which may be defined and calculated differently by other companies, help to explain and enhance the understanding of our results of operations. However, these measures should not be viewed as a substitute for those determined in accordance with
Reconciliation of Combined Ratio to Accident Year Combined Ratio Prior to CAT Losses
The table below illustrates the reconciliation of the combined ratio on a financial and accident year basis.
|
Quarter Ended |
|
Nine Months Ended |
|||||
(In millions of |
2024 |
|
2023 |
|
2024 |
|
2023 |
|
Net premiums earned (a) |
|
|
|
|
||||
Net loss and loss adjustment expenses (b) |
( |
( |
( |
( |
||||
Net policy acquisition expenses (c) |
( |
( |
( |
( |
||||
General and administrative expenses (d) |
( |
( |
( |
( |
||||
Prior years unfavorable (favorable) development (e) |
|
( |
( |
( |
||||
Catastrophe (“CAT”) losses (f)* |
|
|
|
|
||||
|
|
|
|
|
||||
Combined ratio ((b+c+d)/a)** |
86.0% |
73.2% |
80.5% |
74.9% |
||||
Minus: Prior years unfavorable (favorable) development (e/a) |
5.6% |
(12.7%) |
(9.5%) |
(12.4%) |
||||
Accident year combined ratio |
80.4% |
85.9% |
90.0% |
87.3% |
||||
Minus: CAT losses on an accident year basis (f/a) |
9.9% |
4.4% |
10.3% |
8.7% |
||||
Accident year combined ratio prior to CAT losses |
70.5% |
81.5% |
79.7% |
78.6% |
* |
The CAT losses for the quarter ended |
|
|
|
The CAT losses for the quarter ended |
|
The CAT losses for the nine months ended |
The CAT losses for the nine months ended |
|
** |
See “Supplementary Financial Information - Combined Ratio (Unaudited)” |
Non-GAAP Financial Measures
The table below illustrates the split of loss ratio between current accident year, current year CAT losses, which are included in ‘Net loss and loss adjustment expenses’, and prior years’ loss development as follows:
Quarter Ended |
|
Nine Months Ended |
||||||||||||||
2024 |
|
2023 |
|
2024 |
|
2023 |
||||||||||
(in millions of |
Net loss |
|
% of net |
|
Net loss |
|
% of net |
|
Net loss |
|
% of net |
|
Net loss |
|
% of net |
|
Current year net incurred claims and loss ratio |
|
51.5% |
|
37.3% |
|
45.3% |
|
40.5% |
||||||||
Minus: Current accident year CAT losses |
|
9.9% |
|
4.4% |
|
10.3% |
|
8.7% |
||||||||
Minus: Effect of prior years’ development |
|
5.6% |
( |
(12.7%) |
( |
(9.5%) |
( |
(12.4%) |
||||||||
Current Accident year (Prior to CAT losses) |
|
36.0% |
|
45.6% |
|
44.5% |
|
44.2% |
Core Operating Income
Core operating income measures the performance of our operations without the influence of after-tax gains or losses on investments and foreign currencies and other items as noted in the table below. We exclude these items from our calculation of core operating income because the amounts of these gains and losses are heavily influenced by, and fluctuate in part according to, economic and other factors external to the Company and/or transactions or events that are typically not a recurring part of, and are largely independent of, our core underwriting activities and including them distorts the analysis of trends in our operations. We believe the reporting of core operating income enhances an understanding of our results by highlighting the underlying profitability of our core insurance operations. Our underwriting profitability is impacted by earned premiums, the adequacy of pricing, and the frequency and severity of losses. Over time, such profitability is also influenced by underwriting discipline, which seeks to manage the Company’s exposure to loss through favorable risk selection and diversification, IGI’s management of claims, use of reinsurance and the ability to manage the expense ratio, which the Company accomplishes through the management of acquisition costs and other underwriting expenses.
In addition to presenting net income for the period determined in accordance with
Non-GAAP Financial Measures
Core operating income is calculated by the addition or subtraction of certain line items reported in the “Consolidated Statements of Income” from net income for the period and tax effecting each line item (resulting in each item being a non-GAAP measure), as illustrated in the table below:
|
Quarter Ended |
Nine Months Ended |
||||||
(in millions of |
2024 |
2023 |
2024 |
2023 |
||||
Net income for the period |
|
|
|
|
||||
Reconciling items between net income for the period and core operating income: |
|
|
|
|
||||
Net realized gain on investments |
( |
( |
( |
( |
||||
Net unrealized loss (gain) on investments |
|
|
( |
( |
||||
Tax impact of Net unrealized loss (gain) on investments(i) |
|
( |
|
- |
||||
Change in allowance for expected credit losses on investments |
( |
|
|
( |
||||
Tax impact of Change in allowance for expected credit losses on investments(i) |
- |
( |
( |
( |
||||
Change in fair value of derivative financial liabilities |
|
|
|
|
||||
Expense related to conversion of warrants in cash(ii) |
- |
|
- |
|
||||
Net foreign exchange (gain) loss |
( |
|
( |
|
||||
Tax impact of Net foreign exchange (gain) loss(i) |
|
( |
|
( |
||||
Core operating income |
|
|
|
|
||||
Average shareholders’ equity (iii) |
|
|
|
|
||||
Core operating return on average equity (annualized) (iv) and (vi) |
19.8% |
31.0% |
23.2% |
31.4% |
||||
Diluted core operating earnings per share (v) |
|
|
|
|
||||
Return on average equity (annualized) (vi) |
22.3% |
9.3% |
23.5% |
25.8% |
i. |
The tax impact was calculated by applying the prevailing corporate tax rate of each subsidiary to the gross value of the relevant reconciling items as recognized separately by the subsidiaries on a standalone basis. |
|
ii. |
This expense is included in the ‘Other expenses’ line item in the condensed consolidated statements of income. |
|
iii. |
Represents the total shareholders’ equity at the end of the reporting period plus the total shareholders’ equity as of the beginning of the reporting period, divided by 2. |
|
iv. |
Represents annualized core operating income for the period divided by average shareholders’ equity. |
|
v. |
Represents core operating income attributable to vested equity holders divided by weighted average number of vested common shares – diluted as follows: |
|
Quarter Ended |
|
Nine Months Ended |
|||||
(in millions of |
2024 |
|
2023 |
|
2024 |
|
2023 |
|
Core operating income for the period |
|
|
|
|
||||
Minus: Core operating income attributable to earnout shares |
|
|
|
|
||||
Minus: Dividends attributable to restricted share awards |
- |
- |
|
- |
||||
Core operating income available to common shareholders (a) |
|
|
|
|
||||
Weighted average number of shares – diluted (in millions of shares) (b) |
45.8 |
43.0 |
44.6 |
43.7 |
||||
Diluted core operating earnings per share (a/b) |
|
|
|
|
vi. |
Return on average equity (annualized) and core operating return on average equity (annualized), both non-GAAP financial measures, represent the returns generated on common shareholders’ equity during the period. |
The Company has posted a Third Quarter 2024 investor presentation deck on its website at www.iginsure.com in the Investors section under the Presentations & Webcasts tab.
About
Forward-Looking Statements:
This press release contains “forward-looking statements” within the meaning of the “safe harbour” provisions of the Private Securities Litigation Reform Act of 1995. The expectations, estimates, and projections of the business of
View source version on businesswire.com: https://www.businesswire.com/news/home/20241105994802/en/
IGI Contacts:
Investors:
M: + 44 (0) 7384 514785
Email: [email protected]
Media:
Aaida Abu Jaber, AVP PR & Marketing
T: +96265662082 Ext. 407
M: +962770415540
Email: [email protected]
Source:
Assurant Reports Third Quarter 2024 Financial Results
Op-Ed: Here’s How I Believe Kamala Harris’ Campaign Got The Tech Industry To Side With The Democratic Party
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News